COMPOSITION FOR THE PREVENTION AND/OR TREATMENT OF DISEASES ASSOCIATED WITH TNF AND/OR IL-12 OVEREXPRESSION

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20100048492A1
SERIAL NO

12515450

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a pharmaceutical composition comprising at least one compound of formula (I):is chosen from the group comprising a hydrogen atom, a mono-, di-, tri-, tetra- and penta-mannosyl; and the use of such a composition for manufacturing a medication intended for the prevention or treatment of an illness associated with the over-expression of TNF and/or IL-12 in a subject.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS3 RUE MICHEL ANGE PARIS F-75794
UNIVERSITE D'ORLEANSCHÂTEAU DE LA SOURCE BP 6749 F-45067 ORLEANS CEDEX 2

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gilleron, Martine Auzeville Tolosane, FR 4 10
Nigou, Jérôme Auzeville Tolosane, FR 2 5
Puzo, Germain Auzeville, FR 5 11
Quesniaux, Ryffel Valérie Saint-Denis En Val, FR 2 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation